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A single rat gene encodes both fibroblast TM-1 and skeletal muscle ~3-tropomyosin by an alternative RNA- 
processing mechanism. The gene contains 11 exons: Exons 1-5 and exons 8 and 9 are constitutive exons 
common to all mRNAs expressed from this gene; exons 6 and 11 are used in fibroblasts as well as smooth 
muscle; exons 7 and 10 are used exclusively in skeletal muscle. We have studied the internal alternative RNA 
splice choice (exons 6 and 7) of the rat tropomyosin 1 gene in vitro, using nuclear extracts obtained from HeLa 
cells. Use of alternative splice sites in vitro is dependent on the ionic conditions of the assay, and correct 
splicing occurs only under well-defined salt conditions. Splicing of exon 5 to exon 6 (fibroblast-type splice) and 
exon 5 to exon 7 (skeletal muscle-type splice) was dependent on precursors in which exon 6 or 7 was first 
joined to exon 8. The same patterns of alternatively spliced RNAs were formed when similar templates were 
introduced in HeLa cells by transfection. Thus, there appears to be an ordered pathway of splicing in which the 
internal alternatively spliced exons must first be joined to the downstream constitutive exon before they can be 
spliced to the upstream constitutive exon. The data are consistent with a model in which the critical event in 
alternative splicing occurs during the joining of exon 6 to exon 8 (fibroblast-type splice) or exon 7 to exon 8 
(skeletal muscle-type splice). 
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The generation of protein isoform diversity by alterna- 
tive RNA splicing is a fundamental mechanism of eu- 
karyotic gene expression, which contributes to tissue- 
specific and developmentally regulated pattems of gene 
expression {for reviews, see Left et al. 1986; Breitbart et 
al. 19871. Altemative RNA splicing pathways have also 
been demonstrated for a number of viral genes {for re- 
view, see Ziff 1980}. At present, little is known about 
the mechanisms that determine altemative RNA 
splicing of complex transcription units. In particular, it 
is not known how alternative splice sites are selected 
and whether the splicing signals in complex transcrip- 
tion units differ from those in simple transcription 
units. The identified sequence elements required for 
pre-mRNA splicing include the consensus equences 
found at the 5' and 3' splice sites and lariat branch 
points {Mount 1982; Green 1986; Padgett et al. 19861. 
Sequence comparisons between splice junctions of alter- 
native and constitutive xons have failed to identify any 
significant differences, suggesting that these sequences 
alone do not account for the choice between alternative 
splice sites (Breitbart et al. 1987}. It seems likely that 
regulation of splice site selection in transcripts con- 
taining alternative 5' or 3' splice sites will involve other 
cis-acting elements. In addition, a number of studies 
have suggested the existence of trans-acting factors that 
interact with sequence lements in the pre-mRNA to 
promote differential splice site selection (Breitbart and 
Nadal-Ginard 1987; Left et al. 1987}. However, the iden- 
tity of these putative trans-acting factors and the signals 
they recognize remains unknown. 
One example of the use of alternative RNA processing 
for the generation of protein diversity is found in the 
tropomyosin gene family. Tropomyosins comprise a 
family of related actin-binding proteins present in 
muscle {skeletal, cardiac, and smooth} and nonmuscle 
cells. Tropomyosin isoform diversity involves the ex- 
pression of multiple genes, each of which codes for more 
than one isoform by the use of alternatively spliced 
exons. In addition, altemative RNA splicing for the gen- 
eration of tropomyosin isoform diversity appears to be a 
fundamental mechanism conserved throughout evolu- 
tion since it has been characterized in various species, 
including Drosophila {Basi et al. 1984; Karlik and Fyr- 
berg 1986}, chicken (Fiszman et al. 1986), quail (Flach et 
al. 1986; Hallaeur et al. 1987}, rat {Ruiz-Opazo et al. 
1985; Helfman et al. 1986; Ruiz-Opazo and Nadal- 
Ginard 1987}, and human (MacLeod et al. 1985; Reinach 
and MacLeod 1986}. Work from our laboratory has pre- 
viously demonstrated that a single rat gene encodes both 
rat fibroblast TM-1 and skeletal muscle 13-tropomyosin 
by altemative RNA splicing (Helfman et al. 1986}. This 
gene contains 11 exons {see Fig. 11: Exons 1-5 and exons 
8 and 9 are constitutive xons common to all mRNAs 
expressed from this gene; exons 6 and 11 are used in fi- 
broblasts as well as smooth muscle cells; exons 7 and 10 
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are used exclusively in skeletal muscle. In addition, se- 
quence analysis did not reveal any obvious nucleotide 
differences between the common and tissue-specific 
splice junctions that may be important for alternative 
splicing (Helfman et al. 1986). The structural features of 
this gene raise a number of questions concerning the 
mechanisms involved in tissue-specific processing. The 
observation that the same gene can generate unique iso- 
forms in cells as different as skeletal muscle and fibro- 
blasts underscores the importance of regulatory factors 
(cis and trans) that must be implicated in alternative 
RNA processing. However, the nature of these factors is 
not known. 
In this paper we report a series of experiments de- 
signed to study the alternative splicing pathways of tro- 
pomyosin pre-mRNAs in vitro, using nuclear extracts 
obtained from HeLa cells, and in vivo by transient ex- 
pression of minigenes in HeLa cells. Using nuclear ex- 
tracts, the selection of alternative splice sites depends 
on the ionic conditions of the assay, and correct splicing 
occurs only under well-defined conditions. In addition, 
we demonstrate that the internal alternatively spliced 
exons must first be joined to the downstream constitu- 
tive exon before they can be spliced to the upstream 
constitutive exon. These studies uggest the existence of 
an ordered pathway of splicing involved in utilzation of 
the internal alternative xons. 
Results 
Tropomyosin gene constructs used for generation of 
pre-mRNAs for in vitro splicing 
The rat tropomyosin 1 gene gives rise to two mRNAs 
that result from alternative internal exon selection, 3' 
exon selection, and poly(A) site utilization (Fig. 1). We 
prepared a number of DNA templates designed to ana- 
lyze the internal alternatively spliced region of the rat 
tropomyosin 1 gene. These constructions contain 1, 2, or 
3 introns of the region between exons 5 through 8, in- 
serted downstream of the SP6 promoter (see Fig. 2). Pre- 
cursors extending to the SalI site in the polylinker of 
SP64 or to a number of other convenient restriction sites 
can thus be synthesized with SP6 polymerase. 
Splicing of exon 5 to exon 6 (fibroblast-type splice) 
requires sequences in exon 8 
We used a HeLa cell nuclear splicing extract o study 
processing of a series of pre-mRNAs derived from the 
internal alternatively spliced region of the tropomyosin 
gene. We used nuclear extracts derived from HeLa cells 
because human cells contain the same isogene as the rat, 
and HeLa cells express exclusively the same isoform as 
rat fibroblasts, namely TM-1 (MacLeod et al. 1985; 
Helfman et al. 1986). Thus, at the onset of these studies, 
there was good potential for using the HeLa cell system 
to study the cis-acting elements and trans-acting factors 
involved in alternative splice-site selection. We first 
tested the ability of HeLa cell nuclear extracts to splice 
pre-mRNAs that contained exons 5 and 6. Pre-mRNAs 
labeled with 32p were generated from pSP64-p2 linear- 
ized with restriction endonucleases NcoI and StuI (see 
Fig. 3). Precursors prepared from templates linearized 
with NcoI contain 40 nucleotides of exon 6, whereas 
those prepared from templates linearized with StuI con- 
tain all of exon 6 and 17 nucleotides of downstream in- 
tron sequences. When these precursors were processed 
in vitro, no detectable splice products were generated 
(Fig. 3, left and middle panels). Similar results were also 
obtained with precursors obtained from pSP64-p2 linear- 
ized with PstI or XmnI (data not shown). Because the 
MgC12 and KC1 concentrations were found to strongly 
affect in vitro splicing patterns (see below), we also 
tested precursors derived from pSP64-p2 linearized with 
NcoI and StuI under varying ionic conditions. Under the 
incubation conditions examined, we did not detect 
splicing of exon 5 to exon 6 using these precursors (data 
not shown). The lack of splicing of exon 5 to exon 6 
using these pre-mRNAs was unexpected because studies 
of a number of different pre-mRNA substrates have es- 
tablished that removal of most of the 3' exon sequences 
has little apparent effect in the splicing reaction in vitro 
(Furdon and Kole 1986, 1988; Reed and Maniatis 1986; 
Parent et al. 1987; Turnbull-Ross et al. 1988). Thus, the 
results obtained using tropomyosin pre-mRNAs are 
unique when compared with the results obtained in 
other systems. In addition, these results suggest that the 
nucleotide sequences within exon 6 do not contain suf- 
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Figure l. Schematic diagram of the intron/exon organization of the rat tropomyosin 1 gene (Helfman et al. 1986). ([--]) Constitutive 
exons; (~) and {11) tissue-specific exons, as indicated; horizontal lines represent introns (not drawn to scale). Amino acids encoded by
each exon are indicated. The cap site and polyadenylation sites are also indicated. 
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Figure 2. Sp6/tropomyosin transcriptional templates. The DNA templates for use in in vitro transcription with SP6 polymerase are 
shown. All are derived from the internal region of the TM-1 gene {exons 5-81. The arrows indicate the sites of transcription i itiation 
with the SP6 sequences (crosshatched regions} adjacent to the SP6 promoter. In vitro transcription terminates at indicated restriction 
sites. In addition, a number of internal restriction sites are also indicated that can be used for synthesis of truncated substrates. Boxes 
indicate positions of exon 5 {constitutivel, exon 6 (fibroblast and smooth muscle-specific), exon 7 (skeletal muscle-specific}, and exon 
8 {constitutive). Lines represent each intron. The number of nucleotides in each exon and intron are indicated. All constructions are 
derivatives of pSP64-p2. 
ficient information to be recognized as a 3' splice site by 
the splicing machinery. 
The order of intron removal in the tropomyosin pre- 
mRNA in vivo is not known. To determine whether 
splicing of exon 5 to exon 6 required that exon 6 first be 
spliced to exon 8, we constructed plasmid pSP64-p4, 
which contains the region of the cDNA clone encoding 
all the sequences downstream of exon 6 through the 
poly(A} tract used in rat fibroblast TM-1 (see Fig. 21. Sur- 
prisingly, in precursors prepared from pSP64-p4 linear- 
ized with ClaI, exon 5 was spliced efficiently to exon 6 
under standard splicing conditions {Fig. 3, right panel}. 
To determine whether the products indicated in Figure 3 
are associated with accurate splicing of exon 5 to exon 6, 
we carried out primer-extension analysis using a 20-nu- 
cleotide-long a2P-labeled oligodeoxynucleotide corre- 
sponding to sequences in the middle of exon 6 as a 
primer. Sequencing of the primer-extension product 
confirmed that exon 5 was spliced accurately to exon 6 
(data not shown). Virtually identical results were ob- 
tained with precursors derived from pSP64-p4 linearized 
with SalI {data not shown}. The splicing of exon 5 to 
exon 6 observed in Figure 3 was not due simply to the 
length of sequences downstream of exon 6, because pre- 
mRNAs prepared from templates derived from pSP64-p2 
linearized with XmnI and PstI did not exhibit splicing of 
exon 5 to exon 6 (data not shown). In addition, a point 
mutation was introduced in the 3' end of intron 7 in the 
plasmid pSP64-p2, whereby the consensus AG was 
changed to APt. Incubation of precursors derived from 
this template did not result in splicing of exon 5 to exon 
6 nor splicing of exon 5 to exon 7 [data not shown}. 
Thus, splicing of exon 5 to exon 6 is dependent on the 
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Figure 3. Analysis of in vitro splicing products of tropomyosin 
pre-mRNAs. Time course (minl of formation of spliced 
products from transcripts terminating at the NcoI site [left}, 
StuI site {middle) of pSP64-p2, and ClaI site of pSP64-p4 (rightl. 
The assay conditions used forthese studies consisted of 15 ~1 of 
nuclear extract in a final reaction volume of 25 ~1 containing 1
mM MgC12, 500 IxM ATP, 20 mM creatine phosphate, 2.7% {wt/ 
vol} polyvinyl alcohol, 15-30 ng pre-mRNA, 12.8 mM HEPES 
(pH 81, 14% (vol/vol) glycerol, 60 mM KC1, 0.12 mM EDTA, and 
0.7 mM DTT. Schematic representation f products are indi- 
cated; boxes represent exon sequences, and lines represent in- 
tron sequences. 
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alternative xon first being joined to downstream exon 
sequences. 
To determine how much sequence downstream of 
exon 6 in pSP64-p4 was required for splicing of exon 5 to 
exon 6, a series of Ba131 constructions were prepared 
from the CIaI site in pSP64-p4. The various deletions 
were tested for their ability to be spliced in vitro. Figure 
4 {lanes 1-81 shows the results of processing pre- 
mRNAs containing 51-195 nucleotides downstream of 
the 3' splice site. The full-length pre-mRNA derived 
from pSP64-p4 lmearized with ClaI (Fig. 4, lane 1) con- 
tans  76 nucleotides of exon 6, 63 nucleotides of exon 8, 
and 54 nucleotides of exon 9. The length of the corre- 
sponding Ba/31 deletions are indicated in Figure 4. Tran- 
scripts terminating 102-195 nucleotides (Fig. 4, lanes 
1-5)  downstream of the 3' splice site were processed in 
the splicing extract, as indicated by a band corre- 
sponding to the 5' exon (e), free intron 5 lariat (d), splice 
product (c), and intron-exon lariat intermediate (b). On 
the other hand, pre-mRNAs containing 51-88 nucleo- 
tides downstream of the 3' splice site were spliced very 
inefficiently, if at all, as indicated by the lack of free 5' 
exon (e) and free intron 5 lariat (d). Pre-mRNAs con- 
taming <26 nucleotides of exon 8 did not appear to be 
processed (Fig. 4). Thus, splicing of exon 5 to exon 6 did 
not require sequences contained in exon 9 but did re- 
quire some, but not all, of exon 8. 
Alternative splicing in vitro is influenced by ionic 
conditions 
The data presented above in Figures 3 and 4 suggested 
that there may be an ordered pathway involved in utili- 
zation of exon 6 in which splicing of exon 6 to exon 8 
will precede splicing of exon 5 to exon 6. The alternative 
splicing pathways of tropomyosin pre-mRNAs were ex- 
amined in greater detail using pre-mRNAs containing 
exons 5-8 and following the formation of splice 
products over time. A full-length precursor derived from 
pSP64-p2 was spliced in HeLa cell nuclear extracts. A 
time course analysis of the products is shown in Figure 5 
{left}. We observed three processing products corre- 
sponding to {1} free exon 5, {2) exon 5 spliced to exon 8, 
and (3) the free lariat released after ligation of exon 5 to 
exon 8. The intermediates corresponding to the lariat 
and downstream exon sequences expected from the 
splicing of exon 5 to exon 8 did not resolve from the 
precursor on these 4% gels. To determine whether the 
products indicated in Figure 5 are associated with accu- 
rate splicing of exon 5 to exon 8, we carried out primer 
extension analysis using a 20-nucleotide-long a2P-la- 
beled oligodeoxynucleotide corresponding to sequences 
in the middle of exon 8 as a primer {Fig. 5, right}. Figure 5 
{right} shows the time course of the reaction products 
analyzed by primer-extension analysis. One product of 
127 nucleotides appeared after 45 min incubation and 
increased in intensity with longer incubation times. 
This product corresponded to the size of the primer-ex- 
tension product expected if exon 5 was correctly joined 
to exon 8. Sequence analysis of the primer-extension 
product confirmed that exon 5 was spliced accurately to 
exon 8 [data not shown}. A number of shorter primer-ex- 
tension products accumulated in a time-dependent 
manner. One of these (70 nucleotides long; see Fig. 5, 
right) corresponds to the position of a branch point se- 
quence located 24 nucleotides upstream of the 3' splice 
junction of exon 8 (D. Helfman and W.M. Ricci, un- 
publ.). We also analyzed the pre-mRNA generated from 
pSP64-p2 spliced in vitro, by primer-extension a alysis, 
using 32P-labeled oligodeoxynucleotide primers specific 
for exons 6 and 7. In agreement with the data presented 
in Figure 5, no splice products were detected, further in- 
dicating a lack of splicing of exon 5 to exon 6 or 7 {data 
not shown). Thus, the only processing products detected 
Figure 4. In vitro splicing of exon 5 to exon 6 (fibroblast- 
type splice] requires sequences i  xon 8. In vitro splicing 
reactions were carried out for 2 hr, and the a2p-labeled 
RNA products were separated in 4% denaturing polyacryl- 
amide gels. [Right] DNA templates derived from the ClaI 
site of pSP64-p4 by Ba131 nuclease treatment. The assay 
conditions used forthese studies consisted of 15 ¢1 of nu- 
clear extract in a final reaction volume of 25 ~1 containing 
1 mM MgC12, 500 ~M ATP, 20 mM creatine phosphate, 
9..7% (wt/vol} polyvinyl a cohol, 15-30 ng pre-mRNA, 
12.8 mM HEPES (pH 8}, 14% (vol/vol} glycerol, 60 mM KC1, 
0.12 mM EDTA, and 0.7 mM DTT. The positions of the 
precursors and products are indicated: (a) Precursors; (b) 
exon/intron lariat intermediates; {c) spliced RNAs; (d) free 
intron 5 lariat; (e) free exon 5. 
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Figure 5. Analysis of in vitro splicing products of tropomyosin 
pre-mRNAs. {Left) Time course (mini of formation of spliced 
products from transcripts erminating atthe SalI site of plasmid 
pSP64-p2. The a2p-labeled RNA products were separated in 4% 
denaturing polyacrylamide g ls. The assay conditions used for 
these studies consisted of 15 Vd of nuclear extract in a final 
reaction volume of 25 V.1 containing 1 mM MgC12, 500 04 ATP, 
20 mM creatine phosphate, 2.7% (wt/vol} polyvinyl alcohol, 
15-30 ng pre-mRNA, 12.8 mM HEPES {pH 8), 14% {vol/vol} 
glycerol, 60 mM KC1, 0.12 mM EDTA, and 0.7 mM DTT. Sche- 
matic representation f products is indicated; boxes represent 
exon sequences, and lines represent intron sequences. (Right} 
The in vitro processing products hown at left were analyzed by 
primer extension using a a2P-labeled oligodeoxynucleotide 
primer specific for sequences in exon 8. Position of primer-ex- 
tension products corresponding to splice products and interme- 
diates are indicated. 
For altematively spliced pre-mRNA, variations in 
ionic conditions, extract concentration, and extract 
preparation have been reported to affect the choice of 
splice site {Hartmuth and Barta 19871 Reed and Maniatis 
1986~ Schmitt et al. 19871. Therefore, we examined the 
effects of changing the concentrations of KC1 and MgC12 
on splice-site util ization of tropomyosin pre-mRNAs. 
We analyzed the splicing of pre-mRNAs derived from 
pSP64-p2p6 linearized with ClaI. Plasmid pSP64-p2p6 is 
similar to plasmid pSP64-p2, except exon 9 sequences 
have been joined to exon 8. Virtually identical results 
were obtained with both pre-mRNAs [data not shown). 
We first analyzed splicing of the pSP64-p2p6 transcript 
by changing the concentration of MgC12 {Fig. 6}. In com- 
parison with the exon skipping shown in Figure 5, we 
detected splicing of exon 6 to exon 8 as the MgC12 was 
increased from 1 rnM to 3 rnM. In agreement with the 
results presented in Figure 5, exon 5 was spliced to exon 
8 at 1 rnM MgC12 {Fig. 6}. In contrast, as the MgC12 con- 
centration was increased above 1.25 mM MgC12, 
MgCI  2 ( raM)  
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using this substrate were the result of splicing exon 5 to 
exon 8. It was unexpected that exon 5 would be spliced 
to exon 8 using full-length precursors derived from 
pSP64-p2. Because HeLa cells do not express the skeletal 
muscle isoform from the endogenous gene, the lack of 
util ization of exon 7 in vitro was not surprising. How- 
ever, the lack of util ization of exon 6 was unexpected. 
The absence of products util izing the 5' or 3' splice sites 
of exon 6 suggests that either additional f ctors are re- 
quired that the in vitro system is lacking, or that the 
incubation conditions used in Figure 5 (1 mM MgC12 and 
60 mM KC1) are not adequate for alternative splicing. 
-F-]  
Figure 6. Effect of magnesium concentration on alternative 
splicing in vitro. Tropomyosin pre-mRNAs derived from 
pSP64-p2p6 linearized with C1aI were processed for 2 hr in 
vitro, using the assay conditions described in Fig. 3, except he 
magnesium concentration was varied as indicated at the top. 
The splicing products were analyzed on a 4% gel. Schematic 
representation f the products is indicated. The markers are 
a2p-labeled MspI fragments of pBR322 {M). 
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cleavage at the 5' splice site of exon 6 was detected as 
well as splicing of exon 6 to exon 8. Furthermore, above 
2.50 mM MgC12 cleavage at the 5' splice site of exon 6 
was the preferred choice and there was no cleavage at 
the 5' splice site of exon 5 and concomitant splicing of 
exon 5 to exon 8. We also examined the effects of 
changes in KC1 concentration at low MgC12 (1.5 mM) and 
at high MgC12 (2.75 mM) concentrations (Fig. 7). As indi- 
cated in Figure 7, when the in vitro splicing reactions 
were carried out at 1.5 mM MgC12, low KC1 concentra- 
tions (40-70 mM) favored exon skipping wherein exon 5 
was spliced to exon 8, whereas higher concentrations of 
KC1 (70-110 mM)permitted cleavage at the 5' splice site 
of exon 6 and subsequent joining of exon 6 to exon 8. On 
the other hand, at 2.75 mM MgC12, cleavage at the 5' 
splice site of exon 6 was readily detected over a broad 
1.5mM MgCI 2 2.75rnM MgCI 2 
~ooooooOooooooO KC, 
M _~-~{or---m_--_ r--o~:-, (mM)// 
J /  
I Ek - - -  ~ 
m 
• ~//:i i¸ ¸ 
: i :~ 
• ! 
----- [2~ 
Figure 7. Effect of varying ionic conditions on alternative 
splicing in vitro. Tropomyosin pre-mRNAs derived from 
pSP64-p2p6 linearized with ClaI were processed for 2 hr in 
vitro, using the assay conditions described in Fig. 3, except 10 
~1 of nuclear extract was used in a final reaction volume of 25 
~1, and the magnesium and potassium concentrations were 
varied as indicated at the top. The splicing products were ana- 
lyzed on a 4% gel. Schematic representation f the products is 
indicated. The markers are a2p-labeled MspI fragments of 
pBRB22 (M). 
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range of KC1 concentrations (Fig. 7). Under any incuba- 
tion conditions used, neither the 5' or 3' splice site of 
exon 7 was util ized when pre-mRNAs derived from 
pSP64-p2p6 linearized with ClaI were used. Thus, in 
HeLa cell nuclear extracts, use of the correct splice sites 
depends on the ionic conditions of the assay, and alter- 
native splicing occurs only under well-defined salt con- 
ditions. If the splicing reactions are carried out for longer 
periods of t ime (3-5 hr), we can detect some splicing of 
exon 5 to exon 6, but only after exon 6 has first been 
joined to exon 8 {data not shown). 
Splicing of exon 5 to exon 7 (skeletal muscle-type 
splice) requires sequences in exon 8 
It was of interest o determine whether splicing of exon 
5 to exon 7 would also be influenced by joining exon 7 to 
exon 8. Plasmid pSP64-p2(7/8) was constructed to study 
this possibility (Fig. 2). When an RNA precursor derived 
from pSP64-p2(7/8) was incubated in vitro, an RNA 
product of the size expected for splicing of exon 5 to 
exon 7 was observed (Fig. 8, left). To confirm that this 
product represented accurate splicing of exon 5 to exon 
7, we carried out primer extension analysis using a 20- 
nucleotide-long a2p-labeled oligodeoxynucleotide corre- 
sponding to sequences in the middle of exon 7 as a 
primer (Fig. 8, right). As indicated in Figure 8, a primer 
extension product of 129 nucleotides was obtained, cor- 
responding to the size of the primer extension product 
expected if exon 5 was correctly joined to exon 7. This 
primer extension product was sequenced, and results 
confirmed that the RNA product was spliced as indi- 
cated (data not shown). Splicing of exon 5 to exon 7 was 
not due simply to the length of of sequences down- 
stream of exon 7 because pre-mRNAs prepared from 
templates derived from pSP64-p2 linearized with XmnI 
which would contain 140 nucleotides of intron 7, do not 
exhibit splicing of exon 5 to exon 7. In addition, there 
was no indication that either the 5' or 3' splice site of 
exon 6 was util ized with this substrate. Thus, splicing of 
exon 5 to exon 7 in HeLa cell nuclear extracts was found 
to occur ff the alternative xon was first joined to exon 
8. 
Processing of tropomyosin minigenes in vivo 
The in vitro experiments described above demonstrate 
that splicing of exon 5 to exon 6 or 7 is dependent on one 
of these exons first being joined to exon 8. Because the 
HeLa cell nuclear extracts were able to utilize the 3' 
splice of both exon 6 [fibroblast-type splice) and exon 7 
(skeletal muscle-type splice), it is l ikely that 3' splice- 
site util ization of these exons does not require a cell- 
type-specific splicing machinery. However, one consid- 
eration is that 3' splice-site discrimination was lost 
using the in vitro system. This could be due to the loss 
of a regulatory factor during the extract preparation. For 
example, it is possible that in vivo the 3' splice site of 
exon 7 is subject to negative control, and the factor re- 
sponsible for this was lost or is functionally inactive in 
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Figure 8. In vitro splicing of exon 5 to exon 7 (skeletal 
muscle-type splice) requires sequences in exon 8. (Left) Time 
course (min) of formation of spliced products from transcripts 
terminating at the SalI site of plasmid pSP64-p2(7/8). The 32p_ 
labeled RNA products were separated on 4% denaturing poly- 
acrylamide gels. The assay conditions used for these studies 
consisted of 15 p,1 of nuclear extract in a final reaction volume 
of 25 ~1 containing 1mM MgC12, 500 g~M ATP, 20 rnM creatine 
phosphate, 2.7% (wt/vol) polyvinyl alcohol, 15-30 ng pre- 
mRNA, 12.8 mM HEPES (pH 8), 14% (vol/vol) glycerol, 60 rnM 
KC1, 0.12 mM EDTA, and 0.7 rn~ DTT. Schematic representa- 
tion of products and intermediates is indicated. {Right) In vitro 
processing products hown at left were analyzed by primer ex- 
tension using a a2p-labeled oligodeoxynucleotide prim r spe- 
cific for sequences in the middle of exon 7. Position of the ex- 
tension product corresponding tospliced RNA is indicated. 
the extracts used in the present study. In addition, be- 
cause tissue-specific RNA processing of this gene in- 
volves altemative 3' exon selection and poly(A) site uti- 
lization, the alternative splicing pattems observed in 
vivo may therefore be a consequence of the different 
pre-mRNAs generated by using the two different 3' 
exons. On the other hand, splicing of exon 5 to either 
exon 6 or exon 7 may not be a strictly regulated event 
but may be dependent on either of the altemative xons 
being spliced to exon 8. 
To address these questions in vivo, we constructed 
three minigenes (Fig. 9). These three minigenes contain 
genomic fragments from exons 5-9. HeLa cells were 
transfected with these three plasmid DNAs, and the re- 
sulting transiently expressed cytoplasmic RNAs were 
isolated. The RNA protection analyses of these RNAs, 
Mternative RNA splicing 
as well as RNA isolated from ock-infected cells, were 
carried out using RNA probes derived from cDNA 
clones encoding rat fibroblast TM-1 and skeletal muscle 
B-tropomyosin (Fig. 9). Transient expression of plasmid 
pSV40-2 in HeLa cells resulted in spliced RNA that con- 
tains exons 5 + 6 + 8 + 9 (Fig. 9). No other products 
were observed, and no RNAs were detected that con- 
tained exon 7. Similar results were obtained with 
pSV40-2(6/8). These results were not unexpected be- 
cause HeLa cells express the same tropomyosin isoform 
as rat fibroblasts, namely TM-1, and, therefore, would be 
expected to utilize exon 6 and not exon 7. These results 
also demonstrate that in the absence of the alternative 
3'-end processing that involves exons 10 and 11, HeLa 
cells were able to process these minigenes in a manner 
that reflected the products expected from the endoge- 
nous gene. Interestingly, expression of pSV40-2(7/8) in 
HeLa cells resulted in expression of spliced RNA that 
contains exons 5 + 7 + 8 + 9 (Fig. 9). Thus, in agree- 
ment with the in vitro data, HeLa cells can utilize the 3' 
splice site of exon 7 (skeletal muscle-type splice) if exon 
7 is first joined to exon 8. 
Discussion 
Alternative splice-site selection in vitro 
The results of the present experiments demonstrate hat 
rat tropomyosin pre-mRNAs can be spliced in HeLa cell 
nuclear extracts. In addition, we also show that correct 
splicing occurs only under well-defined salt conditions. 
Utilization of the alternative splice sites was exquisitely 
sensitive to changes in the concentrations of MgC12 and 
KC1 (Figs. 6 and 7). These results are reminiscent of the 
results obtained on alternative splicing of adenovirus 
E1A gene products in vitro demonstrating changes in 
ionic conditions that affect the choice of splice sites 
(Schmitt et al. 1987). The mechanisms responsible for 
these variations in splice-site selection as a function of 
changes in ionic conditions are not known. Splicing re- 
quires multiple components that interact with the pre- 
mRNA to form a functional splicing complex. It is likely 
that different factors have different ionic requirements. 
For example, the interaction of a given snRNP to the 
same or different splice sites may vary as a function of 
ionic conditions. In addition, RNA structure has been 
suggested to play a role in alternative RNA processing 
by regulating the accessibility of different exons to the 
splicing machinery (Khoury et al. 1979; Munroe 1984; 
Solnick 1985; Eperon et al. 1986; Edlind et al. 1987). 
Thus, changes in ionic conditions may effect the struc- 
ture of the pre-mRNA itself, which may, in turn, influ- 
ence the availability of a given splice site. These ques- 
tions can now be studied further with the development 
of an in vitro system that reproduces alternative pro- 
cessing of tropomyosin pre-mRNAs. 
The in vitro experiments have revealed a number of 
features of alternative splicing of tropomyosin pre- 
mRNAs. Of particular interest was the observation that 
splicing of exon 5 to exon 6 (fibroblast-type splice) is de- 
pendent on exon 6 first being joined to exon 8 (Figs. 3 
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Figure 9. RNA analysis of HeLa cells transfected 
with tropomyosin minigenes. (Top) Schematic dia- 
gram of the three tropomyosin minigenes used in 
the HeLa cell transfections. The autoradiograph of 
RNA protection analyses using probes derived from 
cDNA clones encoding rat fibroblast TM-1 (middle 
left) and skeletal muscle B-tropomyosin (middle 
right) of cytoplasmic RNAs from HeLa cells trans- 
fected with the minigenes, as indicated. (Bottom) 
Schematic diagram of the structure of the RNA 
probe and protected fragments {S) corresponding to
spliced RNA from the three minigenes. 
S . . . .  : ~"  S - -  : °  
. ?~ ' : 
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and 4). We also determined that splicing of exon 5 to 
exon 7 (skeletal muscle-type splice) was observed, but 
only if the alternatively spliced exon was first joined to 
exon 8 (Fig. 8). Similar results were obtained in vivo 
using transient expression of tropomyosin minigenes in 
HeLa cells (Fig. 9). These data are consistent with a 
model in which alternative RNA processing is regulated 
during splicing of exon 6 or 7 to the downstream consti- 
tutive exon (see below). However, the biological signifi- 
cance of these studies with respect to the skeletal 
muscle-type splice will require development of in vitro 
systems that accurately reflect the in vivo splicing pat- 
terns observed in skeletal muscle. For example, skeletal 
muscle cells may splice exon 5 to exon 7 independent of
sequences in exon 8. Accordingly, the need for the puta- 
tive tissue-specific factors that permit this splice may 
have been circumvented in the HeLa system by fusing 
exon 8 to exon 7. 
Role of exons and introns in alternative splice-site 
selection 
The reason that the splicing of exon 5 to exon 6 (fibro- 
blast-type splice} and of exon 5 to exon 7 (skeletal 
muscle-type splice} is dependent on either altemative 
exon being joined to exon 8 remains to be determined. 
One explanation is that intron sequences located down- 
stream of an exon may contain sequences that inhibit 
splicing of an upstream intron {Furdon and Kole 19881. 
Accordingly, intron sequences downstream of exon 6 or 
7 could contain sequences that inhibit splicing of these 
exons to exon 5. However, we were unable to detect 
splicing of exon 5 to exon 6 using pre-mRNAs with no 
downstream intron sequences unless at least 26 nucleo- 
tides of exon 8 were joined to exon 6 [Figs. 3 and 41. 
Thus, removal of intron sequences downstream of exon 
6 alone was not sufficient for splicing of exon 5 to exon 
6. At present, we do not know whether the intron se- 
quences downstream of exon 7 are inhibitory to utiliza- 
tion of the 3' splice site of this exon. Another explana- 
tion is that the nucleotide sequences contained in exon 
6, and perhaps exon 7, do not contain sufficient informa- 
tion to interact with splicing factors to form a functional 
splicing complex with respect o util ization of their 3' 
splice sites. Work from a number of laboratories has es- 
tablished a min imum exon length of the 3' exon in the 
splicing reaction (Furdon and Kole 1986, 1988; Reed and 
Maniatis 1986; Parent et al. 1987; Tumbull-Ross et al. 
1988}. These studies have demonstrated a requirement 
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for as little as 20 nucleotides of the 3' exon. The present 
studies demonstrate hat tropomyosin pre-mRNAs con- 
taining all 76 nucleotides of the 3' exon 6 sequences 
were not spliced to exon 5 (Fig. 3). The joining of exon 8 
to exons 6 or 7 may be required for the formation of a 3' 
exon of sufficient length to interact with splicing factors 
and thereby be utilized by the splicing apparatus. In ad- 
dition, exon 8 may contain sequences that represent a
specific splicing signal. 
Studies of alternative RNA splice-site selection of 
SV40 late transcripts and the human fibronectin gene 
demonstrated that mutations within exons can affect 
the choice of splice sites used (Somesekhar and Mertz 
1985; Mardon et al. 1987). Although these studies how 
that alterations in exon sequences affect splice-site se- 
lection, the mechanism responsible for these results re- 
mains to be determined. Exon sequences could, in prin- 
ciple, interact directly with specific components of the 
splicing machinery, and changes in their sequences 
could therefore affect binding sites. In addition, exon 
and intron sequences may contribute to RNA secondary 
structures. RNA secondary structure has been suggested 
to play a role in alternative RNA processing by regu- 
lating the accessibility of different exons to the splicing 
machinery (Khoury et al. 1979; Munroe 1984; Solnick 
1985; Eperon et al. 1986; Edlind et al. 1987). Whether the 
joining of exons 6 and 7 to exon 8 results in changes in 
RNA secondary structure and, subsequently, alterations 
in splice-site selection is unknown. It is possible that 
either of the altemative xons may be sequestered and 
unable to interact with the splicing machinery due to 
RNA folding. Such potential secondary structures could 
involve intron sequences upstream, as well as down- 
stream, of a given exon. Alternatively, specific se- 
quences within introns could interact with factors that 
facilitate or stabilize the formation of secondary struc- 
tures. The joining together of two exons and thereby re- 
moving a flanking intron may prevent the formation of 
RNA structures that interfere with the interaction of a 
given 5' or 3' splice site with splicing factors. 
Utilization of internal alternative 3' splice sites does 
not require tissue-specific factors 
Regulation of alternative splice-site selection in vivo 
could be the result of cell-type-specific splicing ma- 
chinery that can only use the 5' or 3' splice sites of the 
alternatively spliced exons. Using both in vitro and in 
vivo systems, we were able to demonstrate splicing of 
exon 5 to exon 7 (skeletal muscle-type splice) when the 
latter exon was first joined to exon 8 (Figs. 8 and 9). The 
ability of HeLa cell nuclear extracts and HeLa cells to 
splice exon 5 to exon 7 was unexpected because this 
splice occurs exclusively in skeletal muscle in vivo 
{Helfman et al. 1986). Because the HeLa cell nuclear ex- 
tracts and intact cells were able to utilize the 3' splice 
sites of both exon 6 {fibroblast-type splice) and exon 7 
(skeletal muscle-type splice), it seems likely that 3' 
splice-site utilization of these exons does not require a 
cell-type-specific splicing machinery. Hence, utilization 
Alternative RNA splicing 
of the 5' splice sites of exons 6 and 7 may be the only 
cis-sequences that need to be regulated for tissue-spe- 
cific splicing. 
Model for alternative splice-site selection 
The data presented in the present studies are consistent 
with a model in which the critical event in alternative 
splicing occurs during the joining of exon 6 to exon 8 
(fibroblast-type splicel or exon 7 to exon 8 (skeletal 
muscle-type splicel. This model proposes that the 
splicing machinery in fibroblasts and smooth muscle 
cells promotes the joining of exon 6 to exon 8, whereas 
the splicing machinery in skeletal muscle promotes the 
joining of exon 7 to exon 8. The precise nature of this 
regulation is not known. Altemative RNA processing 
may be the result of specialized factors that recognize 
the relevant splice site directly, or there may be tissue- 
specific positive or negative regulators that control the 
interaction of a general splicing factor with the alterna- 
tive splice sites. For example, recognition of the 5' splice 
sites of either exon 6 or exon 7 may require tissue-spe- 
cific factors that directly interact with these splice sites, 
i.e., a tissue-specific U1 snRNP. Altemative RNA pro- 
cessing may occur by the regulation f RNA structure in 
such a way as to favor or prevent he use of a particular 
splice site by the general splicing machinery. Such a 
model has been proposed for altemative RNA processing 
in calcitonin/CGRP gene expression (Leff et al. 1987). In 
addition, we do not know whether splicing of exon 6 to 
exon 8 and exon 7 to exon 8 are both regulated processes 
that each require cell-specific trans-acting factors. 
Splicing of exon 6 to exon 8 may simply reflect he 'con- 
stitutive' pathway of splicing, whereas plicing exon 7 to 
exon 8 requires tissue-specific factors expressed in skel- 
etal muscle. For example, studies of alternative RNA 
processing of the calcitonin/CGRP gene have suggested 
that expression of calcitonin mRNA is a constitutive 
pathway, whereas CGRP mRNA likely involves neuron- 
specific splicing factors (Left et al. 1987). On the other 
hand, studies of the troponin T gene have suggested that 
tissue-specific factors are required for use of both consti- 
tutive and alternatively spliced exons (Breitbart et al. 
1987). In the future, it will be of interest o determine 
whether utilization of both of the alternatively spliced 
exons in the tropomyosin gene will require tissue-spe- 
cific splicing factors. 
Finally, the studies presented in this paper may have 
broad implications in studying alternative RNA splicing 
as a mechanism to regulate the expression of specific 
protein isoforms in different cell types. There are a 
number of cellular and viral genes that contain internal 
alternatively spliced exons such as fibronectin, growth 
hormone, troponin T, and tropomyosin (for references, 
see Leff et al. 1986; Breitbart et al. 1987). In these cases, 
it will be of interest o determine whether splicing will 
follow an ordered pathway in which the internal alterna- 
tively spliced exons must first be joined to the down- 
stream constitutive xon before they can be spliced to 
the upstream constitutive xon. 
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Experimental procedures 
Plasmid constructions 
The DNA templates for use in in vitro transcription with SP6 
polymerase are shown in Figure 2. All are derived from the 
rat fibroblast TM-1 gene (Helfman et al. 1986). pSP64-p2 was 
constructed by first deleting sequences from the unique ClaI 
site in exon 9 with Bal31 to 17 nucleotides 3' of exon 8. The 
DNA was then digested at a unique Bali site in exon 5. The DNA 
was modified with HindIII linkers and cloned into the HindlII 
site of SP64. Thus, SP64-p2 contains an SP6 promoter with 14 
nucleotides of plasmid sequence, including the HindlII linker 
following the SP6 RNA initiation site and 66 nucleotides of 
exon 5 and genomic sequence xtending 17 nucleotides 3' of 
exon 8. Plasmid pSP64-p4 was derived from SP64-p2 by ligating 
the NcoI-SalI fragment of the cDNA clone encoding rat fibro- 
blast TM-1 (Yamawaki-Kataoka and Helfman 1985) to the 
NcoI-SalI sites of pSP64-p2. Plasmids pSP64-4(1-8) (Fig. 5) 
were obtained from pSP64-p4 by first digesting pSP64-p4 with 
ClaI. The DNA was then treated with Ba131 nuclease, then the 
Klenow fragment of DNA polymerase I to generate blunt ends, 
followed by ligation to ClaI linkers. Plasmid pSP64-p2(7/8) was 
derived from pSP64-2 by removal of the intervening sequence 
between exons 7 and 8 using a 30-nucleotide-long deoxyoligo- 
nucleotide containing 15 nucleotides of exon 7 and 15 nucleo- 
tides of exon 8 {Eghtedarzadeh and Henikoff 1986). Plasmid 
pSP64-p2p6 was constructed by joining the regions of the 
cDNA encoding fibroblast TM-1 corresponding to exons 9-11 
to pSP64-p2. 
For studies designed to analyze the internal alternatively 
spliced region of the rat TM-1 gene in vivo, the initial construc- 
tion contains a 1.0-kb BalI-ClaI fragment that begins at the 5' 
region of exon 5 and extends through the 3' region of exon 9. 
This fragment was modified with HindlII linkers and cloned 
into the unique HindIII site located 70 bp downstream of the 
transcriptional start site in the eukaryotic expression vector 
pXICH (D. Hanahan, unpubl.). This plasmid, herein referred to 
as pSV40-2, contains the SV40 early promoter and a functional 
poly(A) site flanking genomic tropomyosin sequences con- 
taining exons 5-9 (Fig. 9). Plasmid pSV40-2(6/8) was derived 
from pSV40-2 by removal of the genomic sequences between 
exons 6 and 8 using a 30-nucleotide-long deoxynucleotide con- 
taming 15 nucleotides of exon 6 and 15 nucleotides of exon 8 
(Eghtedarzadeh and Henikoff 1986). Similarly, plasmid pSV40- 
2(7/8) was derived from pSV40-2 by removal of intron se- 
quences between exons 7 and 8 using a 30 nucleotide long 
deoxynucleotide containing 15 nucleotides of exon 7 and 15 
nucleotides of exon 8 (Eghtedarzadeh and Henikoff 1986). 
Synthesis of RNA and in vitro splicing 
The a2p-labeled SP6/tropomyosin transcripts were synthesized 
in vitro primed with cap analog, as described (Konarska et al. 
1984). The a2p-labeled pre-mRNAs contained a small amount of 
prematurely terminated transcripts, but their presence did not 
appear to effect the in vitro splicing reactions, and the RNA 
substrates were not purified further. 
HeLa cell nuclear extracts were prepared as described 
(Dignam et al. 1983; Krainer et al. 1984). In vitro splicing reac- 
tions were carried out at 30°C for indicated times (0-240 rain). 
Standard assay conditions used for these studies consisted of 15 
~1 of nuclear extract in a final reaction volume of 25 ~1 con- 
taining 1 mM MgC12, 500 ~lvi ATP, 20 mM creatine phosphate, 
2.7% {wt/vol) polyvinyl alcohol, 15-30 ng pre-mRNA, 12.8 mM 
HEPES (pH 8), 14% (vol/vol) glycerol, 60 mM KC1, 0.12 mM 
EDTA, and 0.7 mM dithiothreitol (DTT]. In some experiments, 
the concentrations of MgC12 and KC1 were varied as indicated. 
To vary the KC1 concentration, the in vitro reactions were per- 
formed using 10 wl of nuclear extract in a final reaction volume 
of 25 wl. 
Analysis of processing products 
After incubation for the indicated time, the reactions were 
stopped by addition of a solution containing SDS-proteinase K, 
and the RNA recovered as described (Krainer et al. 1984). The 
products of the reaction were analyzed on denaturing urea- 
polyacrylamide gels. Intermediates were distinguished from 
final products by their relative appearance and disappearance in 
time course experiments. Lariat RNAs were identified by their 
aberrant mobility on different percentage polyacrylamide gels 
(Grabowski et al. 1984; Ruskin et al. 1984). In addition, RNAs 
containing lariats were verified through treatment by a lariat 
debranching activity (Ruskin and Green 1985). Processing 
products were also analyzed by primer-extension a alysis and 
S1 nuclease protection analysis using cDNA clones derived 
from fibroblast TM-1 and skeletal muscle ~-tropomyosin 
(Helfman et al. 1986). Primer extension analysis was carried out 
essentially as described (Ghosh et al. 1978; Erster et al. 1988). 
Oligodeoxynucleotides complementary to sequences encoding 
amino acids 198-204 within exon 6 (5'-GAGAGCCTGGTC- 
CATGGTTC-3'), amino acids 198-204 within exon 7 (5'- 
CAAGTTGTTGGTAACAATTT-3'), and amino acids 223-229 
within exon 8 (5'-TCCTGAAGTTTGATCTCCTT-3') of the rat 
fibroblast TM-1 gene were used as primers. Primers were end 
labeled with [~-32p]ATP using T4 polynucleotide kinase. The 
primers were annealed to the RNA by incubation for 3 min at 
55°C and then 30 min at 37°C in 30 ~1 of primer-extension 
buffer [50 mM Tris-HC1 (pH 8.3), 140 mM KC1, 10 raM MgC12]. 
For primer extension, reactions were transferred to 42°C and 
supplemented with DTT (final concentration of 5 InM) and 
deoxynucleotide triphosphates (final concentration f 0.5 mM) 
and 10 units of avian myeloblastosis virus reverse transcriptase. 
After 30 rain, the reactions were terminated by addition of 
EDTA to a final concentration f 25 raM, and the radiolabeled 
pre-mRNA was degraded by treatment with RNase A prior to 
gel electrophoresis. To sequence the primer extension products, 
the standard splicing reactions were scaled up 10- to 30-fold, 
the primer-extension products were resolved on sequencing 
gels, and the bands cut out of gels, recovered, and subjected to 
sequence analysis {Maxam and Gilbert 1980). 
Transfections and RNA analysis 
HeLa cells were grown in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% CS (calf serum). HeLa cells 
were transfected with 5 ~g of plasmid DNA per 100-mm plate 
using a calcium phosphate coprecipitation procedure, and the 
cells were harvested 48 hr later. For preparation ofcyctoplasmic 
RNA, each 100-mm plate of HeLa cells was washed three times 
with ice-cold phosphate-buffered saline (PBS); the cells were 
scraped from the plates with a rubber policeman i  1 ml of PBS 
and transferred toa microfuge tube. The cells were centrifuged 
for 15 sec and resuspended in 375 ~1 of ice-cold buffer con- 
taining 150 mM NaC1, 1.5 mM MgC12, and 10 mM Tris-HC1 {pH 
8.0); 10% NP-40 was then added to a final concentration of 
0.5% to lyse the cells. The nuclei were pelleted by a 2-min cen- 
trifugation in the cold room, and the supematant was trans- 
ferred to a clean tube containing 4 wl of 20% SDS and 5 ~1 of 
proteinase K{10 mg/ml). The mixture was incubated at 37°C for 
15 rain and extracted with phenol, and the nucleic acids were 
precipitated with ethanol. The RNA preparations were then 
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treated with DNase in the presence of RNasin and reprecipi- 
tated. 
RNase protection assays were carried out as described (Zinn 
et al. 1983). The plasmids used for synthesis of a2P-labeled anti- 
sense RNA were derived from cDNA clones encoding rat fibro- 
blast TM-1 and skeletal muscle B-tropomyosin. The plasmids 
were prepared by inserting the PstI-ClaI fragments of the fibro- 
blast and skeletal muscle cDNA clones into pSP64. The PstI 
site, corresponding toamino acids 144 in exon 4, was modified 
with EcoRI linkers, and the ClaI site, corresponding to amino 
acids 252 in exon 9, was modified with HindIII linkers. The 
resulting EcoRI-HindIII fragments were ligated into an EcoRi- 
HindIII double-cut pSP64 vector. Plasmid was linearized with 
EcoRI and transcribed with SP6 polymerase to yield a transcript 
of -330 nucleotides. Because the transfected genes do not con- 
tam sequences in exon 4, it was possible to distinguish RNA 
derived from the transfected genes from endogenous mRNA. 
Hybridizations contained 10 ~g of total cytoplasmic RNA and 
500,000 dpm of tropomyosin probe, in a total volume of 30 gJ. 
All subsequent s eps were carried out as described previously 
(Zinn et al. 1983), except he RNase digestions were carried out 
at 30°C for 60 rain. 
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